Current understanding of the genetics of thoracic aortic disease

Abstract

Thoracic aortic dissection is a feared, highly lethal condition most commonly developing from aneurysmal dilation of the thoracic aorta. Elective prophylactic replacement of thoracic aortic aneurysms dramatically mitigates this risk. However, diagnosis of a thoracic aortic aneurysm can be challenging. Thoracic aortic disease - horacic aortic aneurysm and dissection (TAAD) - can be sporadic or heritable. Patients with syndromic heritable TAAD present with classic phenotype and clinical features correlating to their disease. In contrast, patients with non-syndromic heritable disease are harder to diagnose due to their lack of defining uniform phenotypes. Recent advances in genomics have begun to elucidate the genetic underpinnings of non-syndromic TAAD (ns-TAAD) for better understanding this complex disease and improve diagnosis and management. Herein, we review the foundation of knowledge in ns-TAAD heritability and key research studies identifying gene mutations in vascular smooth muscle cells, the extracellular matrix, and TGF-beta signaling present in ns-TAAD. We summarize the current guidelines for the diagnosis, screening, and surgical management of ns-TAAD including recommendations for genetic testing of high-risk individuals. Finally, we highlight areas of future research that will continue to advance our understanding of the complex genetic and epigenetic factors in TAAD.

Keywords

Thoracic aortic disease / genomics / thoracic aortic aneurysm / thoracic aortic dissection

References

[1] Tanaka Y,Sakurai Y.Prevalence of type A acute aortic dissection in patients with out-of-hospital cardiopulmonary arrest.Am J Cardiol2016;117:1826-30

[2] Melvinsdottir IH,Agnarsson BA,Gudbjartsson T.The incidence and mortality of acute thoracic aortic dissection: results from a whole nation study.Eur J Cardiothorac Surg2016;50:1111-7

[3] Guo MH,Saczkowski R.Association of Mortality and acute aortic events with ascending aortic aneurysm: a systematic review and meta-analysis.JAMA Netw Open2018;1:e181281 PMCID:PMC6324275

[4] Mok SC,Mansour A.Twenty-five year outcomes following composite graft aortic root replacement.J Card Surg2017;32:99-109

[5] Goldfinger JZ,Marin ML,Eagle KA.Thoracic aortic aneurysm and dissection.J Am Coll Cardiol2014;64:1725-39

[6] Isselbacher EM,Hamilton Black J 3rd.2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the american heart association/american college of cardiology joint committee on clinical practice guidelines.Circulation2022;146:e334-482

[7] Goyal A,Czarny MJ,Mani A.The genetics of aortopathies in clinical cardiology.Clin Med Insights Cardiol2017;11:1179546817709787 PMCID:PMC5457142

[8] Vinholo T, Zafar MA, Ziganshin BA, Elefteriades JA. Nonsyndromic thoracic aortic aneurysms and dissections-is screening possible?.Semin Thorac Cardiovasc Surg2019;31:628-34

[9] Albornoz G,Roberts M.Familial thoracic aortic aneurysms and dissections - incidence, modes of inheritance, and phenotypic patterns.Ann Thorac Surg2006;82:1400-5

[10] Lovatt S,Schwarz K.Misdiagnosis of aortic dissection: a systematic review of the literature.Am J Emerg Med2022;53:16-22

[11] Morentin Campillo B,Monzó Blasco A.Sudden death due to thoracic aortic dissection in young people: a multicenter forensic study.Rev Esp Cardiol2019;72:553-61

[12] Milewicz DM,Park ES.Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections.Am J Cardiol1998;82:474-9

[13] Biddinger A,Coselli J.Familial thoracic aortic dilatations and dissections: a case control study.J Vasc Surg1997;25:506-11

[14] Coady MA,Roberts M.Familial patterns of thoracic aortic aneurysms.Arch Surg1999;134:361-7

[15] Milewicz DM,Hostetler E,Pinard AC.Update on the genetic risk for thoracic aortic aneurysms and acute aortic dissections: implications for clinical care.J Cardiovasc Surg2021;62:203-10 PMCID:PMC8513124

[16] Ma WG,Mok SCM.Positive family history of aortic dissection dramatically increases dissection risk in family members.Int J Cardiol2017;240:132-7

[17] Glotzbach JP,Tonna JE.Familial associations of prevalence and cause-specific mortality for thoracic aortic disease and bicuspid aortic valve in a large-population database.Circulation2023;148:637-47 PMCID:PMC10527074

[18] Chou AS,Mok SC.Do familial aortic dissections tend to occur at the same age?.Ann Thorac Surg2017;103:546-50

[19] Januzzi JL,Fattori R.Characterizing the young patient with aortic dissection: results from the international registry of aortic dissection (IRAD).J Am Coll Cardiol2004;43:665-9

[20] Evangelista A,Bossone E.Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research.Circulation2018;137:1846-60

[21] Olsson C,Ståhle E,Granath F.Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002.Circulation2006;114:2611-8

[22] Robertson EN,Sherrah AG.Familial non-syndromal thoracic aortic aneurysms and dissections - incidence and family screening outcomes.Int J Cardiol2016;220:43-51

[23] Holmes KW,Eagle KA.Cardiovascular outcomes in aortopathy: GenTAC registry of genetically triggered aortic aneurysms and related conditions.J Am Coll Cardiol2022;79:2069-81 PMCID:PMC9205611

[24] Sherrah AG,van der Linde D.Nonsyndromic thoracic aortic aneurysm and dissection: outcomes with marfan syndrome versus bicuspid aortic valve aneurysm.J Am Coll Cardiol2016;67:618-26

[25] Kimura N,Kawahito K.Outcomes of early-onset acute type a aortic dissection - influence of etiologic factors.Circ J2019;83:285-94

[26] Borger MA,Stephens EH.The American association for thoracic surgery consensus guidelines on bicuspid aortic valve-related aortopathy: full online-only version.J Thorac Cardiovasc Surg2018;156:e41-74 PMCID:PMC6413866

[27] Tessler I,Albuisson J.Is bicuspid aortic valve morphology genetically determined? A family-based study.Am J Cardiol2022;163:85-90

[28] Giusti B,De Cario R,Nistri S.Genetic bases of bicuspid aortic valve: the contribution of traditional and high-throughput sequencing approaches on research and diagnosis.Front Physiol2017;8:612 PMCID:PMC5573733

[29] Habchi KM,Vieira VM.Association between bicuspid aortic valve morphotype and regional dilatation of the aortic root and trunk.Int J Cardiovasc Imaging2017;33:341-9 PMCID:PMC6377809

[30] Jackson V,Caidahl K.Bicuspid aortic valve leaflet morphology in relation to aortic root morphology: a study of 300 patients undergoing open-heart surgery.Eur J Cardiothorac Surg2011;40:e118-24

[31] Prakash SK,Muehlschlegel JD.A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium).J Am Coll Cardiol2014;64:832-9 PMCID:PMC4485610

[32] Yassine NM,Body SC.Pathogenic mechanisms of bicuspid aortic valve aortopathy.Front Physiol2017;8:687 PMCID:PMC5622294

[33] Gehlen J,Debiec R.Elucidation of the genetic causes of bicuspid aortic valve disease.Cardiovasc Res2023;119:857-66

[34] Gould RA,Woods CE.ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm.Nat Genet2019;51:42-50 PMCID:PMC6309588

[35] Verstraeten A,Loeys B.Aetiology and management of hereditary aortopathy.Nat Rev Cardiol2017;14:197-208

[36] Brownstein AJ,Ziganshin BA.Genes associated with thoracic aortic aneurysm and dissection: 2018 update and clinical implications.Aorta2018;6:13-20 PMCID:PMC6136681

[37] Wu L.The pathogenesis of thoracic aortic aneurysm from hereditary perspective.Gene2018;677:77-82

[38] Renard M,Ghosh R.Clinical validity of genes for heritable thoracic aortic aneurysm and dissection.J Am Coll Cardiol2018;72:605-15 PMCID:PMC6378369

[39] Takeda N,Fujita D.A deleterious MYH11 mutation causing familial thoracic aortic dissection.Hum Genome Var2015;2:15028 PMCID:PMC4785537

[40] Guo DC,Tran-Fadulu V.Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.Nat Genet2007;39:1488-93

[41] Zhu L,Khau Van Kien P.Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus.Nat Genet2006;38:343-9

[42] Pannu H,Papke CL.MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II.Hum Mol Genet2007;16:2453-62 PMCID:PMC2905218

[43] Harakalova M,de Kovel CG.Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus.Eur J Hum Genet2013;21:487-93 PMCID:PMC3641382

[44] Wang L,Cao J.Mutations in myosin light chain kinase cause familial aortic dissections.Am J Hum Genet2010;87:701-7 PMCID:PMC2978973

[45] Hannuksela M,Klar J.A novel variant in MYLK causes thoracic aortic dissections: genotypic and phenotypic description.BMC Med Genet2016;17:61 PMCID:PMC5008005

[46] Guo DC,Casteel DE.Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.Am J Hum Genet2013;93:398-404 PMCID:PMC3738837

[47] Medina-Martinez O.Foxe view of lens development and disease.Development2007;134:1455-63

[48] Kuang SQ,Guo DC.FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.J Clin Invest2016;126:948-61 PMCID:PMC4767350

[49] Guo DC,Regalado ES.MAT2A mutations predispose individuals to thoracic aortic aneurysms.Am J Hum Genet2015;96:170-7 PMCID:PMC4289682

[50] Lee VS,Hoffman EP.Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.Proc Natl Acad Sci USA2016;113:8759-64 PMCID:PMC4978273

[51] Guo DC,Gong L.LOX mutations predispose to thoracic aortic aneurysms and dissections.Circ Res2016;118:928-34 PMCID:PMC4839295

[52] Barbier M,Aubart M.MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections.Am J Hum Genet2014;95:736-43 PMCID:PMC4259978

[53] Elbitar S,Arnaud P.Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm.Genet Med2021;23:111-22 PMCID:PMC8559271

[54] Brautbar A,Franco LM,Milewicz DM.FBN1 mutations in patients with descending thoracic aortic dissections.Am J Med Genet A2010;152A:413-6 PMCID:PMC3593235

[55] Keramati AR,Farahani MM,Mani A.The non-syndromic familial thoracic aortic aneurysms and dissections maps to 15q21 locus.BMC Med Genet2010;11:143 PMCID:PMC2958900

[56] LeMaire SA,Guo DC.Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.Nat Genet2011;43:996-1000 PMCID:PMC3244938

[57] Milewicz DM,Fisher N,Markello T.Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.Circulation1996;94:2708-11

[58] Lindsay ME,Bolar NA.Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.Nat Genet2012;44:922-7 PMCID:PMC3616632

[59] Boileau C,Hanna N.TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome.Nat Genet2012;44:916-21 PMCID:PMC4033668

[60] Pannu H,Chang J.Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections.Circulation2005;112:513-20

[61] Jondeau G,Regalado E.International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (montalcino aortic consortium).Circ Cardiovasc Genet2016;9:548-58 PMCID:PMC5177493

[62] Regalado ES,Villamizar C.Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms.Circ Res2011;109:680-6 PMCID:PMC4115811

[63] Gong J,Jiang L.In vitro lineage-specific differentiation of vascular smooth muscle cells in response to SMAD3 deficiency: implications for SMAD3-Related thoracic aortic aneurysm.Arterioscler Thromb Vasc Biol2020;40:1651-63 PMCID:PMC7316596

[64] Zhang P,Chen J.Smad4 deficiency in smooth muscle cells initiates the formation of aortic aneurysm.Circ Res2016;118:388-99

[65] Heald B,Moran R.Prevalence of thoracic aortopathy in patients with juvenile polyposis syndrome-hereditary hemorrhagic telangiectasia due to SMAD4.Am J Med Genet A2015;167:1758-62

[66] Teekakirikul P,Miller DT.Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations.Am J Med Genet A2013;161:185-91 PMCID:PMC3535513

[67] Duan XY,Regalado ES.SMAD4 rare variants in individuals and families with thoracic aortic aneurysms and dissections.Eur J Hum Genet2019;27:1054-60 PMCID:PMC6777456

[68] Garg V,Ransom JF.Mutations in NOTCH1 cause aortic valve disease.Nature2005;437:270-4

[69] Mohamed SA,Liptau H.Novel missense mutations (p.T596M and p.P1797H) in NOTCH1 in patients with bicuspid aortic valve.Biochem Biophys Res Commun2006;345:1460-5

[70] McKellar SH,Yagubyan M,Ackerman MJ.Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms.J Thorac Cardiovasc Surg2007;134:290-6

[71] Boodhwani M,Leipsic J.Canadian cardiovascular society position statement on the management of thoracic aortic disease.Can J Cardiol2014;30:577-89

[72] Erbel R,Boileau C.2014 ESC guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The task force for the diagnosis and treatment of aortic diseases of the european society of cardiology (ESC).Eur Heart J2014;35:2873-926

[73] Verhagen JMA,Cozijnsen L.Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives.Int J Cardiol2018;258:243-8

[74] Mariscalco G,Elefteriades JA,Murphy GJ.Systematic review of studies that have evaluated screening tests in relatives of patients affected by nonsyndromic thoracic aortic disease.J Am Heart Assoc2018;7:e009302 PMCID:PMC6201478